25th May 2023 12:14
Renalytix PLC - London-based kidney health-focused diagnostics company - Announces partnership with life-science commercialisation company Eversana Life Science Services LLC. Will expand commercial footprint for diabetic kidney disease prognostic device KidneyIntelX. Device aims to help clinicians better predict chronic kidney disease in adult type 2 diabetes patients. Companies will provide field deployment and training to primary care providers across key US regions this summer, complimenting Renalytix's existing sales efforts in major markets including New York. Renalytix says two large clinical utility studies have shown the product helps clinicians better understand risks to patients, resulting in improved medication use and faster specialist referrals. Expects additional data on the product's real-world utility to be released next month at the American Diabetes Association annual clinical meeting. Read More
